Sanara MedTech (SMTI) Total Non-Current Liabilities (2010 - 2026)

Sanara MedTech's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $48.6 million for Q1 2026.

• Quarterly Total Non-Current Liabilities rose 4.58% year-over-year to $48.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.6 million (up 4.58% YoY) and the FY2025 annual result came in at $48.4 million, up 42.78% from the prior year.
• Total Non-Current Liabilities was $48.6 million for Q1 2026 at Sanara MedTech, roughly flat from $48.4 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $48.6 million in Q1 2026 and bottomed at $187040.0 in Q1 2022.
• A 5-year average of $24.2 million and a median of $18.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slumped 54.8% — and 2023, when it jumped 4116.63%.
• Sanara MedTech's Total Non-Current Liabilities stood at $6.5 million in 2022, then jumped by 138.36% to $15.5 million in 2023, then jumped by 118.43% to $33.9 million in 2024, then surged by 42.78% to $48.4 million in 2025, then advanced by 0.35% to $48.6 million in 2026.
• Business Quant data shows SMTI's Total Non-Current Liabilities at $48.6 million in Q1 2026, $48.4 million in Q4 2025, and $47.6 million in Q3 2025.